I have noticed recently that some shares despite FDA approval, price action is opposite, also earning call sometimes when it beats estimates projection, the market sentiment or price action is in reverse. Which is more important when picking a trade: Earning or FDA outcome Acquisition or Market sentiment Happy to learn from friends here. $Enlivex Therapeutics(ENLV.US)$ $Akebia Therapeutics(AKBA.US)$ $Rekor Systems(REKR.US)$ $OncoCyte(OCX.US)$
$Akebia Therapeutics(AKBA.US)$Bullish engulfing candle on yesterday’s daily! Which held up today! Looking now for trend to continue, at least short term? NFA just thinking outloud
HotShot369樓主 : 如果我平均下跌,ID 接近 1.4,但仍需要回到 1.6-1.75,才能在這裡發揮積極了哈哈